Diagnostic and therapeutic applications of sphingolipid hydrolyzing enzymes.
D000906:Antibodies; D003429:Cross Reactions; D000795:Fabry Disease / Q000175:diagnosis; D005776:Gaucher Disease / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D005962:Glucosylceramidase / Q000378:metabolism / Q000627:therapeutic use; D006026:Glycoside Hydrolases / Q000627:therapeutic use*; D006801:Humans; D008052:Lipid Metabolism, Inborn Errors / Q000175:diagnosis* / Q000188:drug therapy; D013107:Sphingolipids / Q000378:metabolism*; D013661:Tay-Sachs Disease / Q000175:diagnosis
D000906:Antibodies; D013107:Sphingolipids; D006026:Glycoside Hydrolases; D005962:Glucosylceramidase